Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
39 studies found for:    Benign Essential Blepharospasm
Show Display Options
Download search resultsDownload the search results for:
Benign Essential Blepharospasm (39 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Recruiting rTMS and Botulinum Toxin in Benign Essential Blepharospasm
Condition: Benign Essential Blepharospasm
Interventions: Device: Magstim RapidStim2;   Device: Sham Magstim RapidStim2
2 Completed Study of a Single Administration of 3 Doses of Dysport® for the Treatment of Benign Essential Blepharospasm
Condition: Blepharospasm
Intervention: Drug: Botulinum toxin type A (Dysport®)
3 Recruiting Blepharospasm Tools
Conditions: Blepharospasm;   Dystonia;   Other Eye and Face Disorders
Intervention: Other: No intervention.
4 Unknown  Comparison of Different Botulinum Toxin A Injection Patterns in the Treatment of Blepharospasm
Condition: Blepharospasm
Interventions: Procedure: Botulinum toxin A injection (5 sites: 12.5U);   Procedure: Botulinum toxin A injection (4 sites: 10U);   Drug: Botulinum toxin A 12.5U;   Drug: Botulinum toxin A 10U
5 Not yet recruiting Two Different Surgical Methods of Blepharospasm
Condition: Blepharospasm
Interventions: Procedure: Facial nerve combing;   Procedure: Facial and Trigeminal nerve combing
6 Completed Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Conditions: Cervical Dystonia;   Blepharospasm
Intervention: Biological: Xeomin®
7 Completed Blepharospasm Patient Survey for Patients With Blepharospasm
Condition: Blepharospasm
Intervention: Other: No intervention- only one time survey
8 Completed Comparison of Korean Botulinum Toxin Type A Versus Botox in the Treatment of Essential Blepharospasm
Condition: Blepharospasm
Intervention: Drug: Korean Botulinum toxin type A (KbtxA) and Botox injection
9 Completed Brain Changes in Blepharospasm
Condition: Blepharospasm
Intervention:
10 Terminated Blepharospasm Short Interval
Condition: Blepharospasm
Intervention: Drug: NT 201
11 Completed Efficacy and Safety Study of Meditoxin® to Treat Essential Blepharospasm
Condition: Essential Blepharospasm
Intervention: Drug: Botulinum Toxin Type A
12 Completed
Has Results
A Study of Acetyl Hexapeptide-8 (AH8) in Treatment of Blepharospasm
Condition: Focal Dystonia
Interventions: Drug: Acetyl-Hexapeptide Topical Treatment;   Drug: placebo
13 Completed
Has Results
Comparison of Two Botulinum Type A Products in the Treatment of Blepharospasm
Condition: Blepharospasm
Interventions: Biological: Botulinum Toxin Type A 900kDa;   Biological: Botulinum Toxin Type A 150kDa
14 Terminated
Has Results
Acetyl Hexapeptide-8 for Blepharospasm
Condition: Focal Dystonia
Interventions: Drug: Topical acetyl hexapeptide-8;   Drug: Placebo
15 Recruiting Safety and Efficacy of NABOTA in Treatment of Essential Blepharospasm
Condition: Blepharospasm
Intervention: Drug: Clostridium Botulinum Toxin Type A
16 Completed Therapeutic Confirmatory Clinical Trial to Evaluate the Safety and Efficacy of "Hugeltox Inj." in Essential Blepharospasm
Condition: Essential Blepharospasm
Interventions: Drug: Hugeltox;   Drug: Botulinum Toxin Type A(Botox®)
17 Completed Brain Stimulation to Treat Blepharospasm or Meige Syndrome
Conditions: Blepharospasm;   Focal Dystonia
Intervention: Procedure: repetitive transcranial magnetic stimulation (rTMS)
18 Completed
Has Results
IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Blepharospasm
Condition: Blepharospasm
Interventions: Drug: incobotulinumtoxinA (Xeomin);   Drug: Placebo
19 Unknown  Influence of Gaze Shift and Emotions on Symptoms of Blepharospasm
Condition: Pupillary Occlusion
Intervention:
20 Completed
Has Results
A Retrospective Chart Review of BOTOX® and Xeomin® for the Treatment of Cervical Dystonia and Blepharospasm
Conditions: Cervical Dystonia;   Blepharospasm
Intervention: Other: No Intervention

   Previous Page Studies Shown (1-20) Next Page (21-39) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.